Free Trial
OTCMKTS:MSLP

MusclePharm (MSLP) Stock Price, News & Analysis

MusclePharm logo

About MusclePharm Stock (OTCMKTS:MSLP)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
26,442 shs
Market Capitalization
$7 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MSLP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MusclePharm and its competitors with MarketBeat's FREE daily newsletter.

MSLP Stock News Headlines

“Sell Nvidia before earnings”
Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has been chasing the AI giant, Eric says its biggest customers are now its biggest competitors — and that could spell trouble ahead. Instead, he’s urging investors to consider a little-known hardware company that’s already starting to take off. In fact, while Nvidia has slipped over the past 30 days, this “off-the-radar” stock is up 18% — and Eric believes the run is just beginning.tc pixel
The 5 best muscle rubs of 2024
See More Headlines

MSLP Stock Analysis - Frequently Asked Questions

MusclePharm Co. (OTCMKTS:MSLP) announced its quarterly earnings data on Monday, August, 10th. The company reported ($0.51) EPS for the quarter, missing the consensus estimate of ($0.19) by $0.32. The company had revenue of $50.48 million for the quarter, compared to analysts' expectations of $55 million.

Shares of MSLP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MusclePharm investors own include Altimmune (ALT), Avino Silver & Gold Mines (ASM), BellRing Brands (BRBR), Dalradian Resources (DALR), EVRAZ (EVRZF), Humacyte (HUMA) and Rent-A-Center (RCII).

Company Calendar

Last Earnings
8/10/2015
Today
8/23/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:MSLP
CIK
1415684
Fax
N/A
Employees
20
Year Founded
2008

Profitability

EPS (Trailing Twelve Months)
($0.58)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$12.87 million
Net Margins
-38.51%
Pretax Margin
-38.52%
Return on Equity
N/A
Return on Assets
-169.56%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.25
Quick Ratio
0.23

Sales & Book Value

Annual Sales
$50.04 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.94) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
33,390,000
Free Float
13,121,000
Market Cap
$7 thousand
Optionable
Not Optionable
Beta
-0.07

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (OTCMKTS:MSLP) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners